Evidence map›Paper›PMID 39735918›Full record

ReviewJACS Au2024

Ancestral Sequence Reconstruction for Designing Biocatalysts and Investigating their Functional Mechanisms.

Kridsadakorn Prakinee, Suppalak Phaisan, Sirus Kongjaroon, Pimchai Chaiyen

Abstract readReview
In one paragraph

Review in JACS Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Next-Generation Manufacturing: The Evolving Role of Biocatalysis in AstraZeneca.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kridsadakorn PrakineeSchool of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Wangchan Valley, Rayong 21210, Thailand.ORCID https://orcid.org/0000-0003-2421-1518
Suppalak PhaisanSchool of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Wangchan Valley, Rayong 21210, Thailand.
Sirus KongjaroonSchool of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Wangchan Valley, Rayong 21210, Thailand.ORCID https://orcid.org/0009-0007-0351-2326
Pimchai ChaiyenSchool of Biomolecular Science and Engineering, Vidyasirimedhi Institute of Science and Technology (VISTEC), Wangchan Valley, Rayong 21210, Thailand.ORCID https://orcid.org/0000-0002-8533-1604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biocatalysis has emerged as a green approach for efficient and sustainable production in various industries. In recent decades, numerous advancements in computational and predictive approaches, including ancestral sequence reconstruction (ASR) have sparked a new wave for protein engineers to improve and expand biocatalyst capabilities. ASR is an evolution-based strategy that uses phylogenetic relationships among homologous extant sequences to probabilistically infer the most likely ancestral sequences. It has proven to be a powerful tool with applications ranging from creating highly stable enzymes for direct applications to preparing moderately active robust protein scaffolds for further enzyme engineering. Intriguingly, it can also provide insights into fundamental aspects that are challenging to study with extant (current) enzymes. This Perspective discusses a practical strategy for guiding enzyme engineers on how to embrace ASR as a practical or associated protocol for protein engineering and highlights recent examples of using ASR in various applications, including increasing thermostability, expanding promiscuity, fine-tuning selectivity and function, and investigating mechanistic and evolution aspects. We believe that the use of the ASR approach will continue to contribute to the ongoing development of the biocatalysis field. We have been in a "golden era" for biocatalysis in which numerous useful enzymes have been developed through many waves of enzyme engineering via advancements in computational methodologies.

Identifiers

PMID39735918
PMCPMC11672134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.